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Abstract
Objective Firstly, to assess the completeness of ascertainment
in the National Congenital Anomaly System (NCAS), the basis
for congenital anomaly surveillance in England and Wales, and
its variation by defect, geographical area, and socioeconomic
deprivation. Secondly, to assess the impact of the lack of data on
pregnancies terminated because of fetal anomaly.
Design Comparison of the NCAS with four local congenital
anomaly registers in England.
Setting Four regions in England covering some 109 000 annual
births.
Participants Cases of congenital anomalies registered in the
NCAS (live births and stillbirths) and independently registered
in the four local registers (live births, stillbirths, fetal losses from
20 weeks’ gestation, and pregnancies terminated after prenatal
diagnosis of fetal anomaly).
Main outcome measure The ratio of cases identified by the
national register to those in local registry files, calculated for
different specified anomalies, for whole registry areas, and for
hospital catchment areas within registry boundaries.
Results Ascertainment by the NCAS (compared with data from
local registers, from which terminations of pregnancy were
removed) was 40% (34% for chromosomal anomalies and 42%
for non-chromosomal anomalies) and varied markedly by
defect, by local register, and by hospital catchment area, but not
by area deprivation. When terminations of pregnancy were
included in the register data, ascertainment by NCAS was 27%
(19% for chromosomal anomalies and 31% for
non-chromosomal anomalies), and the geographical variation
was of a similar magnitude.
Conclusion The surveillance of congenital anomalies in
England is currently inadequate because ascertainment to the
national register is low and non-uniform and because no data
exist on termination of pregnancy resulting from prenatal
diagnosis of fetal anomaly.
Introduction
A major congenital anomaly affects 2-3% of newborn babies.
Congenital anomalies are an important cause of fetal, neonatal,
and child mortality and morbidity, accounting for 21% of
perinatal and infant deaths in the United Kingdom in 2001.1
Monitoring of anomalies is vital to identify possible clusters and
trends and to address concerns about putative environmental
teratogens. The importance of registering the type and number
of congenital anomalies has been recognised for many years; in
Birmingham, information on congenital anomalies has been
collected since 1949. A national register for England and Wales,
now called the National Congenital Anomaly System (NCAS),
was proposed by the minister of health in 1963 after the thalido-
mide “epidemic,” and this is run by the Office for National Statis-
tics (ONS; www.statistics.gov.uk).2
Notification of anomalies in live and stillbirths to NCAS is
voluntary and usually done through a standard paper form
(SD56) filled in by midwives, health visitors, and other health
professionals. Local congenital anomaly registers have been set
up alongside the NCAS, partly to deal with the known
under-ascertainment3–6 and partly to meet local needs and
research needs, such as the audit of prenatal diagnosis and
research into putative teratogens. Some 50% of births in England
are covered by local congenital anomaly registers. These
registers are all members of the British Isles Network of
Congenital, Anomaly Registers (BINOCAR,
www.statistics.gov.uk/binocar/) and belong to EUROCAT (the
European Network of Congenital Anomaly Registers, www.euro-
cat.ulster.ac.uk). In contrast to the NCAS, these local registers
record fetuses terminated for fetal anomaly. Ascertainment of
cases to the local registers is actively sought and provided from
multiple sources, such as cytogenetic and postmortem reports;
prenatal diagnosis; and paediatric, neonatal, orthopaedic, and
surgical units.
As part of a study of the geographical variation in the preva-
lence of birth defects7 we measured the extent to which the
under-ascertainment in the NCAS data compared with four
local registers, varied by defect, geographical area, and socioeco-
nomic deprivation, during the period 1991-9. We also assessed
the impact of the absence of data on pregnancies terminated
because of fetal anomaly from the national data set.
Methods
We used data from four local English congenital anomaly regis-
ters for comparison with the NCAS. North Thames (West) Con-
genital Malformation Register (NTW) covers 45 000 births per
year; Northern Congenital Abnormality Survey (NorCAS),
33 000 births per year; Wessex Antenatally Diagnosed Congeni-
tal Anomalies Register (WANDA), 25 000 births per year; and
Oxford Congenital Anomaly Register (OXCAR), 6000 births per
year.8–11 The study period was nine years (1991-9) for all registers
except WANDA, which started in 1994 and contributed cases
from 1994 to 1999 inclusive. The four local registers use similar
methods, with active case finding and multiple sources of ascer-
tainment. Each register collects information on all congenital
anomalies occurring in miscarriages after 20 weeks’ gestation, in
live births and stillbirths, and in fetuses terminated after prenatal
diagnosis of anomaly.
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As three of the local registers were not entirely population
based, we reduced their populations to those census wards where
at least 80% of mothers delivered in hospitals reporting to the
register, as calculated from ONS birth data.7 Cases could be allo-
cated to wards on the basis of their postcode at birth. Average
birth coverage in wards was 97%, and only one hospital
catchment area (the lowest geographical area considered) had
coverage below 90%. We extracted cases reported to NCAS for
the same wards and occurring in the same time period covered
by the four local registers. Cases were not matched directly
because of confidentiality constraints in the use of NCAS data.
We therefore compared total numbers of notified cases from the
two sources (NCAS and local registers) by condition. We defined
hospital catchment areas as the collection of census wards in
which most resident mothers delivered in a particular hospital, as
calculated by using ONS data on births. We calculated the
Carstairs deprivation index12 for each enumeration district on
the basis of the 1991 census.
We selected for study major defects for which the degree of
ascertainment is high, agreement on case definition by all regis-
tries is good, and ICD-10 lists specific codes (table).
We calculated the ratio of the number of cases in the NCAS
data to the number in the local register data, overall and by
anomaly type, region, hospital catchment area, and deprivation
group dividing at quintiles. We also used a logistic model to
adjust the results for deprivation group (dividing at quintiles) by
hospital catchment area and region.7 For these models, the
number of NCAS cases was the numerator and the number of
local register cases the denominator. We carried out all analyses
twice; the first analysis excluded terminations of pregnancy
present in local registers and the second included them.
Results
Ascertainment by NCAS was 40% (42% for non-chromosomal
anomalies and 34% for chromosomal anomalies) when termina-
tions of pregnancy were excluded from register data. This varied
markedly by register, hospital catchment area (not shown), and
congenital anomaly subgroup (table, fig 1); all variations were
significant (P < 0.001).
When terminations of pregnancy were included in register
data, ascertainment of cases by NCAS (compared with the regis-
ters) was 27% (31% for non-chromosomal anomalies and 19%
for chromosomal anomalies; table) and again varied markedly by
register (fig 1), hospital catchment areas within register areas (fig
2), and congenital anomaly subgroup; all variations were signifi-
cant (P < 0.001).
The lowest ascertainment was for neural tube defects (11%
when terminations are in the local register data, 68% when
Table 1 Congenital anomalies studied in the National Congenital Anomaly System (NCAS) for England and Wales and four local congenital anomaly registers
in England, 1991-9. Values are numbers of cases unless otherwise indicated
Anomaly group and subgroups NCAS
Local registries (terminations
excluded)*
NCAS cases as % of local registry
cases (terminations excluded)*
All cases in registries (terminations
included)*
NCAS cases as % of
all registry cases*
All cases 2483 6240 40 9245 27
Type of anomaly
All chromosomal anomalies† 555 1641 34 2927 19
Down’s syndrome 428 834 51 1496 29
All non-chromosomal anomalies‡ 1928 4599 42 6273 31
Some specific non-chromosomal
anomalies:
All neural tube defects 119 176 68 1041 11
Spina bifida 84 112 75 457 18
Cardiac anomalies (excluding
ventricular septal defects)
241 1800 13 2050 12
Hypoplastic left heart 19 98 19 181 11
Fallot’s tetralogy 26 140 19 151 17
Cleft lip 452 547 83 601 75
Cleft palate 208 292 71 307 68
Digestive system (fistulas and
atresias)
188 415 45 471 40
Gastroschisis§ 58 132 44 146 40
Exomphalos§ 28 58 48 106 26
Diaphragmatic hernia§ 29 85 34 123 24
Cystic kidneys 82 299 27 393 21
Limb reduction 217 246 88 296 73
* One of the four local registers provided data for 1994-9 only.
† Includes anomalies coded with the following ICD10 codes: Q90-94, Q96-99.
‡Includes anomalies coded with the following ICD10 codes: Q00-03, Q041-042, Q05, Q110-112, Q160, Q172, Q20, Q211-219, Q22-23, Q25-26, Q300-348, Q36-37, Q35, Q390-394, Q41, Q42,
Q600-605, Q61, Q641-643, Q645, Q71-73, Q77, Q78, Q790-793,
§Analysis limited to 1995-9 to achieve coding comparability between NCAS and local register data.
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Fig 1 Percentage of all defects in the NCAS compared with local registers, by
register
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terminations are removed) and cardiac defects (12% with termi-
nation included and 13% with termination excluded from local
data). The highest ascertainment to NCAS was for cleft lip (75%
and 83% with termination included and excluded from local
data, respectively) and for limb reduction defects (73% and 88%
with terminations included and excluded from local data,
respectively).
Figure 1 shows the variation in ascertainment in NCAS
across local register areas. The highest ascertainment to NCAS
was from the regions covered by NTW and WANDA and the
lowest from the OXCAR area. However, ascertainment from the
different locations was not consistent when individual defects
were compared. For example, ascertainment for cleft lip (overall
ascertainment 75%) was highest (91%) from NorCAS area and
lowest (44%) from OXCAR. Ascertainment of atresias and fistu-
las of the digestive system (overall ascertainment 40%) was high-
est from WANDA and OXCAR areas (57% and 69%) and lowest
from NTW and NorCAS (33% and 37%).
The proportion of cases ascertained by NCAS varied little by
area deprivation (fig 3), certainly less than could be explained by
chance (P > 0.1). This pattern did not change on adjustment for
differences in ascertainment by registry and hospital catchment
area.
Discussion
Surveillance of congenital anomalies in England is currently
inadequate. NCAS identified only 40% of the live and stillborn
cases it was set up to survey. Moreover, NCAS identified little
more than a quarter of all cases including terminations, which
are now numerically important in England. Whether termina-
tions were included or excluded, case ascertainment, while
always low, varied by anomaly, register, and hospital catchment
area. Some hospitals or trusts were clearly giving a higher prior-
ity to notification of congenital anomaly than others. Some of the
variation between anomalies is explained by the fact that those
obvious at birth (such as cleft lip, limb defects) are more likely to
be ascertained than “hidden” defects (such as renal anomalies,
cardiac defects), which may be diagnosed after mother and child
have left the maternity unit. Under-ascertainment by NCAS has
long been known to be a problem.3–6
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Purpose of surveillance and deficiencies of the current
system
The original and main purpose of the NCAS is surveillance over
time. If levels of under-ascertainment remain constant it is still
possible to monitor substantial increases in notifications.
However, there is no way of knowing whether an increase in
notification is due to improved ascertainment or to a true
increase in incidence. Further, for other uses of the data,13 14 con-
stant ascertainment over time does not ensure against bias due
to under-ascertainment.
In an attempt to redress the deficiencies, electronic transmis-
sion of data on live births and stillbirths from some registers
(Wales and Trent) to the national register was instituted in 1998
and 199915 and from others, including those participating in this
study, more recently. This will presumably bring the standard of
national registration of live births and stillbirths to that of local
registries where these exist. However, at present only 50% of
births in England are covered by local registers.Moreover, NCAS
data before 1999 have been used in epidemiological stud-
ies.13 14 16
Impact of terminations
Prenatal diagnosis of congenital anomalies by ultrasound exami-
nation, cytogenetic testing, or molecular genetic testing has
become increasingly available during the past 30 years—that is,
since the NCAS was set up. Given that for some anomalies
(Down’s syndrome, neural tube defects) most pregnancies with
affected fetuses in England result in termination of pregnancy,
17 18 the lack of data on termination of pregnancy in NCAS is an
important omission. The number of terminations carried out
varies geographically, probably because of differences in prena-
tal screening practice. Data from statutory notifications of termi-
nations are collected by the Department of Health, but these data
are relatively inaccessible and have never been validated in terms
of their completeness or of the accuracy of malformation coding.
A change in the NCAS system to enable data on terminations for
fetal anomaly to be recorded on the national register would
result in a much more valuable data set.
Impact of poor national data
The poor quality of NCAS data has implications for the
interpretation of epidemiological studies seeking to establish
risks of congenital anomaly related to residence in relation to
environmental pollution sources.16 Such studies need to be
retrospective in order to collect large enough case numbers for
analysis.7 Low ascertainment levels leave a potential for substan-
tial bias if ascertainment is higher or lower near pollution
sources. It is reassuring that we could find no ascertainment bias
in relation to socioeconomic deprivation. However, given the
high level of variation in ascertainment between hospital
catchment areas, we recommend that a minimum requirement
in using these data is to take this into account in statistical analy-
ses. Communicating results to the public may be difficult when
families are aware that their affected child was more likely not to
be included in the data than to be included.
Impact of local data
Ascertainment by local registers is not 100%, but, given the active
ascertainment of cases from multiple sources, it is not surprising
that they have more complete and accurate data than those on
the national register. The variation in NCAS ascertainment ratio
between registers has a different pattern and is greater than what
is known of variation in local register ascertainment.7 For exam-
ple, we know that NorCAS has more complete ascertainment of
some postnatally diagnosed anomalies than the other three reg-
isters. To communicate effectively locally and to ensure high
quality of local data and their valid interpretation, local registries
cooperate closely with medical specialties such as medical genet-
ics, paediatrics, obstetrics, and pathology, as well as using epide-
miological expertise. Therefore a hierarchical system of local
data collection, which feeds into a national register (as is the case
for cancer registration), should be the most effective model of
national surveillance. However, for this system to work it would
be necessary for the whole population to be covered by local
registers. This does not necessarily mean that all local registers
should follow the same model—some may be more research ori-
ented than others, particularly with regard to aetiological
factors—but we recommend a basic surveillance dataset.
Outlook
If it is important to conduct surveillance of congenital anomalies
to look for associations with potential environmental teratogens,
to support health service planning, and to monitor prenatal
diagnosis and screening programmes then ascertainment of
defects at national level must be improved. We support moves to
obtain data from local registers, to extend coverage of local reg-
isters to the whole country, and to institute an effective national
data collection system for terminations of pregnancy.
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